SC
Savant Capital Portfolio holdings
AUM
$16.1B
1-Year Return
14.38%
This Quarter Return
+0.12%
1 Year Return
+14.38%
3 Year Return
+48.07%
5 Year Return
+73.78%
10 Year Return
+154.4%
AUM
$13.8B
AUM Growth
+$1.07B
(+8.4%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
39.27%
Holding
1,673
New
256
Increased
846
Reduced
438
Closed
85
Top Buys
Top Sells
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$37.1M |
| 2 |
Dimensional US Marketwide Value ETF
DFUV
|
+$27.3M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$20.2M |
| 4 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$18.8M |
| 5 |
SPDR Portfolio S&P 500 ETF
SPLG
|
+$18.1M |
Sector Composition
| 1 | Technology | 5.74% |
| 2 | Financials | 3.65% |
| 3 | Healthcare | 2.99% |
| 4 | Industrials | 2.85% |
| 5 | Consumer Discretionary | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Provident Financial Services
PFS
$2.6B
| $174K | ﹤0.01% |
10,111
-820
| -8% | -$14.1K |
|
1452
MDU Resources
MDU
$3.29B
| $172K | ﹤0.01% |
10,174
-6
| -0.1% | -$101 |
|
1453
Vale
VALE
$44.6B
| $170K | ﹤0.01% |
17,051
-9,653
| -36% | -$96.3K |
|
1454
Ironwood Pharmaceuticals
IRWD
$184M
| $168K | ﹤0.01% |
+114,349
| New | +$168K |
|
1455
The Honest Company
HNST
$447M
| $160K | ﹤0.01% |
+33,945
| New | +$160K |
|
1456
Goodyear
GT
$2.46B
| $159K | ﹤0.01% |
+17,245
| New | +$159K |
|
1457
Wabash National
WNC
$470M
| $159K | ﹤0.01% |
+14,397
| New | +$159K |
|
1458
Harmony Gold Mining
HMY
$9.1B
| $159K | ﹤0.01% |
+10,759
| New | +$159K |
|
|
MEGI
1459
MainStay CBRE Global Infrastructure Megatrends Term Fund
MEGI
$746M
| $158K | ﹤0.01% |
11,875
| – | – |
|
1460
Dr. Reddy's Laboratories
RDY
$11.9B
| $158K | ﹤0.01% |
11,979
-1,971
| -14% | -$26K |
|
1461
Myriad Genetics
MYGN
$643M
| $157K | ﹤0.01% |
+17,648
| New | +$157K |
|
1462
Telefonica
TEF
$30.2B
| $156K | ﹤0.01% |
33,556
+13,852
| +70% | +$64.6K |
|
1463
Harmonic Inc
HLIT
$1.13B
| $156K | ﹤0.01% |
+16,279
| New | +$156K |
|
1464
Fortrea Holdings
FTRE
$937M
| $156K | ﹤0.01% |
+20,666
| New | +$156K |
|
1465
Day One Biopharmaceuticals
DAWN
$765M
| $151K | ﹤0.01% |
+19,006
| New | +$151K |
|
1466
Turkcell
TKC
$4.73B
| $150K | ﹤0.01% |
24,145
+3,283
| +16% | +$20.4K |
|
|
EFC
1467
Ellington Financial
EFC
$1.37B
| $145K | ﹤0.01% |
+10,924
| New | +$145K |
|
1468
Dana Inc
DAN
$2.72B
| $145K | ﹤0.01% |
+10,864
| New | +$145K |
|
1469
Xeris Biopharma Holdings
XERS
$1.25B
| $145K | ﹤0.01% |
26,373
+4,257
| +19% | +$23.4K |
|
1470
MRC Global
MRC
$1.26B
| $142K | ﹤0.01% |
12,338
+1,985
| +19% | +$22.8K |
|
|
VERV
1471
DELISTED
Verve Therapeutics
VERV
| $140K | ﹤0.01% |
+30,722
| New | +$140K |
|
|
FINV
1472
FinVolution Group
FINV
$1.97B
| $139K | ﹤0.01% |
14,384
-183
| -1% | -$1.76K |
|
1473
BrightView Holdings
BV
$1.36B
| $135K | ﹤0.01% |
+10,493
| New | +$135K |
|
1474
Recursion Pharmaceuticals
RXRX
$2.02B
| $135K | ﹤0.01% |
+25,434
| New | +$135K |
|
1475
TeraWulf
WULF
$3.61B
| $133K | ﹤0.01% |
48,799
+13,304
| +37% | +$36.3K |
|